Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (sustain-2)
Ewa Wajs, Leah Aluisio, Richard Holder, Ella J. Daly, Rosanne Lane, Pilar Lim, Joyce E. George, Randall L. Morrison, Gerard Sanacora, Allan H. Young, Siegfried Kasper, Ahmad Hatim Sulaiman, Cheng Ta Li, Jong Woo Paik, Husseini Manji, David Hough, Jennifer Grunfeld, Hong Jin Jeon, Samuel T. Wilkinson, Wayne C. DrevetsJaskaran B. Singh
Research output: Contribution to journal › Article › peer-review
192Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: Assessment of long-term safety in a phase 3, open-label study (sustain-2)'. Together they form a unique fingerprint.